Mar. 17 at 11:02 PM
$QNC
From the investor presentation in February (Francis Bellido):
• Over 35 years of international experience in Cybersecurity, Healthcare and Financial industries.
• Appointed CEO of Quantum eMotion Inc (QNC.V) in Jan 2020
• From 2007 to 2014, he served in several top executive positions in large, medium-sized and startup companies.
• Occupied several executive positions with Eli Lilly in the United States and Europe including
Strategic Asset Director, Global Business Unit Manager and Head of Regulatory Affairs.
• From 1999 to 2006, he managed a
$350M life science investment Fund (SGF-Santé) and produced several major winners:
• Cryocath, sold to Medtronics for
$450 M
• IDI-GeneOhm, sold to Beckton Dickinson for
$350 M
• Draxis, sold to Jubilant for
$255 M
• Medicago, sold to Mitsubichi Pharma for
$550 M
• Atrium, sold for
$750-million to European private equity firm Permira
• Axcan Pharma sold to TPG Capital and Affiliates for US
$1.3 Billion